The Spectrum of Pathogenic Yeast Infection in a Tertiary Care Hospital in Assam, India.
antifungal susceptibility
bloodstream infection
candida
cryptococcus
emerging yeast
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
14
11
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
20
12
2022
Statut:
epublish
Résumé
In view of the growing incidence of pathogenic yeast infection all over the world, this study was undertaken to understand its etiology and epidemiology in Assam. To characterize and study the antifungal susceptibility pattern of the pathogenic yeasts from the clinical samples. The study was a hospital-based cross-sectional study. 150 patients were enrolled in the study and from which clinical samples were collected. A total of 83 samples showing the growth of yeast in culture were included in the study. The yeasts were identified by conventional and BioMerieux ID 32C and VITEK 2 Data was analyzed using statistical software Epi-Info 7.1.2.0 (2013; CDC, Atlanta, USA). For comparison of categorical data, the Chi-square test or Fisher exact test was used. A value of The most affected population was the age group of ≤10 years (32.5%) with male preponderance (67.5%). Yeasts were mostly isolated bloodstream infections (49.3%). The major risk factor was prolonged antibiotic intake. Predominant yeast isolates were The study reflects that there is a growing incidence of emerging yeast infections and efforts are to be made for their identification and antifungal susceptibility testing for the initiation of appropriate therapy.
Identifiants
pubmed: 36532931
doi: 10.7759/cureus.31512
pmc: PMC9751386
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e31512Informations de copyright
Copyright © 2022, Saha et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Diagn Microbiol Infect Dis. 2000 Apr;36(4):215-23
pubmed: 10764963
J Clin Microbiol. 1990 Nov;28(11):2565-7
pubmed: 2254431
Indian J Med Microbiol. 2007 Apr;25(2):146-9
pubmed: 17582187
J Mycol Med. 2020 Dec;30(4):101014
pubmed: 32800427
BMC Genomics. 2015 Sep 07;16:686
pubmed: 26346253
Infect Control Hosp Epidemiol. 2005 Jun;26(6):553-8
pubmed: 16018431
Intensive Care Med. 2015 Feb;41(2):285-95
pubmed: 25510301
Korean J Lab Med. 2010 Aug;30(4):364-72
pubmed: 20805708
J Med Microbiol. 2006 Sep;55(Pt 9):1301-1302
pubmed: 16914664
Ann Lab Med. 2021 Nov 01;41(6):559-567
pubmed: 34108283
N Am J Med Sci. 2013 Sep;5(9):541-5
pubmed: 24251272
Mycobiology. 2016 Jun;44(2):99-104
pubmed: 27433120
J Clin Microbiol. 2007 Jun;45(6):1735-45
pubmed: 17442797
J Med Microbiol. 2006 Feb;55(Pt 2):237-239
pubmed: 16434718
Lancet Infect Dis. 2011 Feb;11(2):142-51
pubmed: 21272794
Indian J Med Res. 2016 Apr;143(4):495-501
pubmed: 27377507
J Mycol Med. 2020 Sep;30(3):100966
pubmed: 32317216
Front Microbiol. 2018 May 29;9:1119
pubmed: 29896181
Future Med Chem. 2018 May 1;10(9):987-1002
pubmed: 29683339
J Clin Microbiol. 2001 Dec;39(12):4420-5
pubmed: 11724855
Infection. 2007 Jun;35(4):256-9
pubmed: 17646917